Opioid industry presses for settlement as trial looms

With a trial looming, major drug distributors and manufacturers are pressing to settle thousands of claims against them related to the nation’s persistent opioid crisis. The companies are negotiating with state attorneys general as jury selection is expected to wrap up on Thursday in the first federal trial over an overdose epidemic that has claimed more than 400,000 American lives […]

Continue reading »

Sick Americans turning to medical pot for help

(HealthDay)—More Americans use marijuana to help them cope with an illness than just to get high, a new study finds. Nearly 46% of those who use pot say they do so because of a medical condition, compared with 22% who say they use marijuana for recreation. And only 36% of those with a medical problem say they use pot to […]

Continue reading »

Nancy Pelosi unveils an ambitious plan to lower drug prices

Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to negotiate prices for the 250 costliest drugs, including insulin. Pharmaceutical companies that refuse to negotiate could face […]

Continue reading »

Oxycontin maker Purdue offers $10-12 bn for opioid claims: report

Purdue Pharma, whose prescription painkiller Oxycontin is blamed for much of the US opioid addiction epidemic, has offered $10-12 billion to settle thousands of claims against the company, NBC News reported Tuesday. The company, whose wealthy owners the Sackler family have come under international scorn for aggressively pushing the prescription drug, is in settlement talks in Cleveland, Ohio ahead of […]

Continue reading »

Cancer drug data release set to power next wave of therapeutic discovery

This week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and exploration which will power genetic research into cancer treatment worldwide. The freely available data set includes unique data comparing almost 1,000 cancer cell lines’ responses to 453 licensed and experimental drugs. The project, led by researchers […]

Continue reading »

Supply of opioids predicts long-term use in injured workers

(HealthDay)—The number of days supplied of an initial opioid prescription is the strongest risk factor for developing long-term opioid use among previously opioid-free injured workers, according to a study published online July 17 in JAMA Network Open. Zoe Durand, Ph.D., from the Tennessee Department of Health in Nashville, and colleagues examined the prevalence and risk factors of long-term opioid use […]

Continue reading »

Dupixent approved for chronic rhinosinusitis with nasal polyps

Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today. Dupixent, which is administered through injection, was previously approved to treat eczema in patients 12 years and older and as an add-on maintenance treatment for moderate-to-severe eosinophilic asthma or oral corticosteroid-dependent asthma. The recommended dose for adult patients […]

Continue reading »
1 2 3